NCT02939274 2018-07-20
An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer
Rogers Sciences Inc.
Phase 2 Unknown
Rogers Sciences Inc.
National Cancer Institute (NCI)